Notably, while the benefits of AMPK activators are attributed to reduced ER-stress and apoptosis, it is possible that recovery from pneumonia is also mediated by enhanced clearance of apoptotic cells. Here, PRKAA1 is linked to susceptibility to pneumonia measurement.